Abstract
Bone biopsies of 52 histologically confirmed alcoholic cirrhotic patients and 15 age- and sex-matched controls have been histomorphometrically analyzed determining trabecular bone volume (TBV), mineralized bone volume (MBV), and osteoid volume (OV). We also determined serum PTH, 25-OH-D3, calcitonin, FSH, LH, estradiol, testosterone, T3 and T4, urine cortisol, routine liver function tests, serum and urinary calcium, phosphorus, and magnesium. We found a high prevalence of osteoporosis: TBV was significantly lower in cirrhotic patients (T=7.23, P<0.001), 41 of them being in the range of osteoporosis; none of them had osteomalacia. Levels of all the above-mentioned hormones and electrolytes were almost normal, and no correlation was found between them and liver function tests, as occurred with the bone parameters.
Similar content being viewed by others
References
Parfitt AM, Kleerekoper M: The divalent ion homeostatic system—physiology and metabolism of calcium phosphorus, magnesium and bone.In Clinical Disorders of Fluid and Electrolyte Metabolism. M Maxwell, C Kleeman (eds). New York, McGraw-Hill, 1980, pp 269–398
Parsons, J: Bone tissue: An overview of structure and function. Clin Invest Med 5:141–147, 1982
Raisz, LG, Kream BE: Regulation of bone formation, part I. N Engl J Med 309(l):29–34, 1983
Raisz LG, Kream BE: Regulation of bone formation, part II. N Engl J Med 309(2):83–90, 1983
Gallager JC, Rigg BL, DeLuca HF: Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. J Clin Endocrinol 51:1359–1364, 1980
Frame B: Osteomalacia—overview.In Clinical Disorders of Bone and Mineral Metabolism. B Frame, JT Pott, Jr (eds). Amsterdam, Excerpta Medica, 1983, pp 215–219
Holick M, Krane S, Pott JT Jr: Vitamin D.In Harrison's Principles of Internal Medicine. RG Petersdorf, RD Adams, E Braunwald, KJ Isselbacher, JB Martin, JD Wilson (eds). New York, McGraw-Hill, 1987, pp 1860–1865
Compston JE, Thompson RP: Intestinal absorption of 25 hydroxy vitamin D and osteomalacia in primary biliary cirrhosis. Lancet 1:721–724, 1977
Wills MR, Savory J: Vitamin D metabolism and chronic liver disease. Ann Clin Lab Sci 14(3): 189–197, 1984
Bouillon R, Auwery J, Dekeyer L, Fevery J, Lissens, W, DeMoor P: Serum vitamin D metabolites and their binding protein in patients with liver cirrhosis. J Clin Endocrinol Metab 59:86–89, 1984
Dibble JB, Sheridan P, Hampshire R, Hardy GJ, Losowsky, MS: Evidence for secondary hyperparathyroidism in the osteomalacia associated with chronic liver disease. Clin Endocrinol 15:373–383, 1981
Davies R, Talmage RV: Evidence for liver inactivation of PTH. Endocrinology 66:312–315, 1960
Gordon GG, Southern AL: Metabolic effects of alcohol on the endocrine system.In Metabolic Aspects of Alcoholism. CS Lieber (ed). Lancaster, MTP Press, 1977, pp 249–302
Peng T, Giterlman HJ: Ethanol induced hypocalcemia, hypomagnesemia and inhibition of the serum calcium raising effects of PTH in rat. Endocrinology 94:608–613, 1974
Tuma DJ, Jennett RB, Sorrell MF: Effect of ethanol on the synthesis and excretion of hepatic secretory glycoproteins and albumin. Hepatology 1:590–597, 1981
Editorial: Hepatic osteodystrophy. Lancet. 2:988–989, 1977
Compston JE, Thompson RP: Hepatic osteodystrophy. Lancet 1:1151, 1977 (letter)
Long RC: Hepatic osteodistrophy. Br J Hosp Med 2:312–321, 1978
Urbain G, Caroli J: Troubles du metabolisme phosphocalcique au cours des cirrhoses du foie. Discussion du role de la corticotherapie. Pathol Biol 34(21–22):1665–1671, 1958
Patri B, Le Charpentier Y, Gueris J, Calmentter MC, Dubrysay J: Vitamine D, parathormone, calcitonine et histomorphometrie osseuse chez les cirrhotiques. Rev Rhum Mal Osteo-Articulaires 45(11):631–640, 1978
Mobarhan SA, Russel RM, Recker RR, Posner DB, Iber FL, Miller P: Metabolic bone disease in alcoholic cirrhosis. A comparison of the effect of vitamin D2, 25 hydroxyvitamin D or supportive treatment. Hepatology 4:266–273, 1984
Le Charpentier Y, Patri B, Dubrisay Y, Forest M, Daudet-Monsac M, Carlioz A, Abelhnet R: L'os due cirrhotique: Etude morphometrique et biologique. Sem Hop Paris 55(21–22): 1101–1104, 1979
Herlong HF, Recker RR, Maddrey WC: Bone disease in primary biliary cirrhosis. Histologic features and response to 25 hydroxyvitamin D. Gastroenterology 83:103–108, 1982
Marloff DS, Kaplan MM, Neer RM, Goldberg MJ, Bitman W, Wolfe HI: Osteoporosis in primary biliary cirrhosis: Effects of 25 hydroxyvitamin D3 treatment. Gastroenterology 83:97–102, 1982
Dibble JB, Sheridan P, Hampshire R, Hardy GI, Losowsky MS: Osteomalacia, vitamin D deficiency, and cholestasis in chronic liver disease. QJ Med 51:89–103, 1982
Bengoa JM, Sitrin MD, Meredith S, Kelly SE, Shah N, Bakor AL, Rosenberg IH: Intestinal calcium absorption and vitamin D status in chronic cholestatic liver disease. Hepatology 4:261–265, 1984
Epstein O, Ajdukiewicz AB, Dock R, Sherlock S: Hypertrophic hepatic osteoarthropathy. Clinical, roentgenologic, biochemical, hormonal and cardiorespiratory studies and review of the literature. Am J Med 67:88–97, 1979
Paterson CR, Losowsky MS: The bone in chronic liver disease. Scand J Gastroenterol 2:293–300, 1967
Cuthbert JA, Pak CV, Zerwern JE, Gars KD, Combes B: Bone disease in primary biliary cirrhosis: Increased bone resorption and turnover in the absence of osteoporosis or osteomalacia. Hepatology 4:1–8, 1984
Bordier P, Matrajt H, Misavet L, Hioco D: Measure histologique de la masse et de la resorption des travees osseuses. Pathol Biol (Paris) 12:1238–1243, 1964
Torres A, Lorenzo V, Gonzalez-Posada JM: Comparison of histomorphometry and computerized tomography of the spine in quantitating trabecular bone in renal osteodystrophy. Nephron 44(4):282–287, 1986
Merz, WA, Schenk RK: Quantitative structural analysis of human cancellous bone. Acta Anat 75:54, 1970
Gonzalez-Reimers CE, Santolaria-Fernandez F, Pestana-Pestana M, Jorge-Hernandez JA, Batista-Lopez N, Abreu-Gonzalez J, Hernandez-Nieto L: Valor cliníco y pronõstico de la fibrosis cuantificada en la cirrosis hepãtica alcohõlica. Rev Esp Enferm Apar Dig 68:413–419, 1985
Bengmark S: Régimen quirũrgico de la hipertensíon portal. Clín Gastroenterol 3(2). 172–201, 1977
Parfitt AM: Investigación de los trastornos de las glándulas paratiroides. Chín Endocrinol 2(3):27–49, 1975
Ask-Upmark E: Hepatic osteomalacia. Acta Med Scand 96:390, 1935
Long RC, Varghese Z, Meinhard EA, Skinner RK, Wills MR, Sherlock S: Parenteral 1-25 dihydroxycholecalciferol in hepatic osteomalacia. Br Med J 1:75–77, 1978
Arlet P, Botreau Y, Blasco A, Vigoni F, Gaillemin C, Duffaut M, Tallec Y: Metabolisme du calcium et de la vitamine D au cours des hepatopathies alcoholiques. Rev Med Interne 1:71–79, 1980
Long RG: Endocrine aspects of liver disease. Br Med J 280:225–228, 1980
Baker HWC, Burger HG, Kretser DM, Paulsen CA, Purcell N, Rennie GC, Seah CS, Taft HP, Wang C: A study of the endocrine manifestations of hepatic cirrhosis. Q J Med 177:145–178, 1976
Long RG, Wills MR, Skinner RK, Sherlock S: Serum 25 hydroxy vitamin D in untreated parenchymal and cholestatic liver disease. Lancet 2:650–652, 1976
Lund B, Sorensen OH, Hilden M, Lund B: The hepatic conversion of vitamin D in alcoholics with varying degrees of liver affection. Acta Med Scand 202:221–224, 1977
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jorge-Hernandez, J.A., Gonzalez-Reimers, C.E., Torres-Ramirez, A. et al. Bone changes in alcoholic liver cirrhosis. Digest Dis Sci 33, 1089–1095 (1988). https://doi.org/10.1007/BF01535783
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01535783